SolGel Technologies Ltd. (SLGL) Moves 9.7% Higher: Will This Strength Last?Zacks Investment Research • 04/16/21
SolGel Technologies Ltd. (SLGL) Stock Jumps 10.8%: Will It Continue to Soar?Zacks Investment Research • 03/11/21
SolGel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/04/21
Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate UpdateGlobeNewsWire • 03/04/21
Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference and H.C. Wainwright Global Life Sciences ConferenceGlobeNewsWire • 02/24/21
Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C. Wainwright BioConnect ConferenceGlobeNewsWire • 01/11/21
Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the Treatment of Acne VulgarisGlobeNewsWire • 12/07/20
Sol-Gel Technologies (SLGL) Looks Good: Stock Adds 8.8% in SessionZacks Investment Research • 12/01/20
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate UpdateGlobeNewsWire • 11/12/20
Sol-Gel to Present at Upcoming Healthcare Investor Conferences in November 2020GlobeNewsWire • 11/09/20
Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of RosaceaGlobeNewsWire • 09/10/20
Sol-Gel Technologies Collaboration Partner Filed First-to-File Paragraph IV Certification for Duobrii®GlobeNewsWire • 09/03/20
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate UpdateGlobeNewsWire • 08/06/20
Sol-Gel Technologies to Report Second Quarter 2020 Financial Results on August 6, 2020GlobeNewsWire • 07/29/20
Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021GlobeNewsWire • 07/28/20
Sol-Gel Technologies Announces Agreements with Perrigo Company for Three New Generic Product CandidatesGlobeNewsWire • 06/29/20
Sol-Gel to Present at Virtual BMO 2020 Prescriptions for Success Healthcare ConferenceGlobeNewsWire • 06/16/20
Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate UpdateGlobeNewsWire • 05/14/20
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase Ordinary SharesGlobeNewsWire • 02/14/20
Sol-Gel Announces Positive Topline Results from Open-Label, Long-Term Safety Study of Epsolay® for Treatment up to 52 WeeksGlobeNewsWire • 02/13/20